Table 2.
Group A | Group B | Group C | |
Number of patients2 | 32 | 55 | 28 |
Initial triglycerides (mg/dl, +/- SD) | 170 ± 53 | 184 ± 49 | 255 ± 205 |
Final triglycerides (mg/dl, +/- SD) | 139 ± 43 | 153 ± 35 | 165 ± 60 |
Delta (+/- SD) | -31 ± 21 | -31 ± 25 | -90 ± 187 |
P value (pre-post) | <0.001 | <0.001 | 0.01 |
Initial low density lipids (LDL; mg/dl, +/- SD) | 150 ± 30 | 156 ± 36 | 152 ± 44 |
Final LDL (mg/dl, +/- SD) | 129 ± 28 | 143 ± 32 | 147 ± 34 |
Delta | -21 ± 26 | -12 ± 16 | -5 ± 34 |
P value (pre-post) | <0.001 | <0.001 | NS |
Initial high density lipids (HDL; mg/dl, +/- SD) | 42 ± 7.0 | 44 ± 6.7 | 47 ± 14.9 |
Final HDL (mg/dl, +/- SD) | 43 ± 6.6 | 45 ± 6.7 | 48 ± 15.3 |
Delta (+/- SD) | 0.9 ± 2.9 | 0.8 ± 3.3 | 1.4 ± 8.8 |
P value (pre-post) | NS | NS | NS |
NS = Not significant.
1 See footnotes to Table 1
2 Patients with pre and post lipid profile analyses